Struck = removed from the bill ·
added = the amendment's new text.
House File 2501 -H-8125 IntroducedAmend HOUSEHouse FILEFile 2501 BYas COMMITTEEfollows: ON JUDICIARY (SUCCESSOR TO HSB 600) A BILL FOR An Act relating to civil actions involving asbestos and silica, and including applicability provisions.
BE1. IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
TLSBPage 5524HV2, (4)line 8818, ko/jhafter H.F.<APPLICABILITY.> by inserting <1.> 2.
2501Page Section2, 1.after line 21 by inserting:
Section<2. 686B.3, subsection 2, Code 2020, is amended to read as follows:
2.This Act shall not apply to an asbestos action, including an action alleging a nonmalignant or malignant condition, or a silica action involving silicosis, filed by a veteran.
AAn plaintiff in an asbestos action, including an action allegingfiled aby nonmalignant or a malignantveteran condition,on or aafter silicaJuly action1, involving2020, silicosis, shall includebe withgoverned theby detailedsection narrative686B.3, medicalCode report2020. file with the petition or other initial pleading a sworn information form containing specifying the evidence that provides the basis for each claim against each defendant.
TheFor swornpurposes informationof formthis shallsubsection, include“veteran” allmeans of the followingsame withas specificity:defined in section 35.1.> 3.
a.By renumbering, redesignating, and correcting internal references as necessary.
The______________________________ name,MEYER address, date of birth,Polk socialHF2501.3658 security(3) number,88 marital-1- status,ko/jh occupation,1/1 current and past worksites, and employer of the exposed person, and any person through whom the exposed person alleges exposure .
b.
The plaintiff’s relationship to the exposed person or person through whom the exposure is alleged.
b.
Each person through whom the exposed person was exposed to asbestos or silica, and the exposed person’s relationship to each person.
c.
Each asbestos-containing product or silica product, whether from a bankrupt entity or otherwise, to which the exposed person was exposed, or if the exposed person was exposed through another person, to which that person was exposed.
c.
d.
The specific location and manner of each alleged exposure, including the specific location and manner of exposure for any person through whom the exposed person alleges exposure was exposed to asbestos or silica.
d.
e.
The beginning and ending dates of each alleged exposure and the frequency of the exposure of the exposed person to the product or its use, including for any person through whom the exposed person was exposed .
e.
f.
The identity of the manufacturer or seller of the specific asbestos or silica product for each exposure.
f.
The identity of the defendant or defendants against whom LSB 5524HV (4) 88 -1- ko/jh 1/3 H.F.
2501 the plaintiff asserts a claim.
g.
The specific asbestos-related or silica-related disease claimed to exist.
h.
Any supporting documentation relating to the information required under this subsection.
Sec.
2.
Section 686B.3, subsection 3, Code 2020, is amended by striking the subsection.
Sec.
3.
Section 686B.3, subsection 5, Code 2020, is amended to read as follows:
5.
The court shall dismiss the asbestos action or silica action without prejudice on finding that the plaintiff has failed to make the prima facie showing required by this chapter or failed to comply with the requirements of this section subsections 1 and 2 .
The court shall dismiss the asbestos action or silica action without prejudice as to any defendant whose product or premises is not identified in the information required pursuant to subsection 2.
Sec.
4.
APPLICABILITY.
This Act applies to an asbestos action, including an action alleging a nonmalignant or malignant condition, or a silica action involving silicosis filed on or after July 1, 2020.
EXPLANATION The inclusion of this explanation does not constitute agreement with the explanation’s substance by the members of the general assembly.
This bill relates to civil actions involving asbestos and silica.
The bill requires a plaintiff in an asbestos action, including an action alleging a nonmalignant or a malignant condition, or a silica action involving silicosis, to file with the petition or other initial pleading a sworn information form specifying the evidence that provides the basis for each claim against each defendant.
The sworn information form must contain the information as detailed in the bill.
Current law does not require a plaintiff in an asbestos action, including an action alleging a malignant condition, or a silica action LSB 5524HV (4) 88 -2- ko/jh 2/3 H.F.
2501 involving silicosis, to file a sworn information form stating the basis for each claim against each defendant.
The bill directs the court to dismiss an asbestos action or a silica action without prejudice on finding that a plaintiff has failed to make a prima facie case.
The court is also required to dismiss an asbestos action or silica action without prejudice as to each defendant whose product or premises is not identified in the sworn information.
The court shall also dismiss the action without prejudice as to all defendants if the plaintiff fails to comply with the requirements for the sworn statement or the requirement that the plaintiff file a detailed medical report.
The provisions in the bill apply to asbestos actions, including actions alleging a nonmalignant or malignant condition, or silica actions involving silicosis filed on or after July 1, 2020.
LSB 5524HV (4) 88 -3- ko/jh 3/3